IBEX.NASDAQIbex LTD

DEF: IBEX Limited 2025 Proxy: Strong Financials, Governance Shift

Sentiment:

Proxy Statement


IBEX Limited's 2025 proxy statement details strong financial growth, a shift from controlled company status, and proposals for its Annual General Meeting.

Better than expectedNet income increased to $36.864 million in FY2025 from $33.655 million in FY2024.Adjusted Net Income increased to $43.001 million in FY2025 from $38.351 million in FY2024.EBITDA increased to $64.798 million in FY2025 from $60.961 million in FY2024.Adjusted EBITDA increased to $71.955 million in FY2025 from $65.176 million in FY2024.Free Cash Flow increased to $27.293 million in FY2025 from $27.045 million in FY2024.

Summary

  • The 2025 Annual General Meeting of Shareholders will be held virtually on December 5, 2025, at 4:00 p.m. Eastern Time.
  • Shareholders will vote on five key proposals: setting the maximum number of directors at eight, electing eight director nominees, authorizing the Board to fill any vacancies, approving the Amended and Restated Ibex Limited 2020 Long-Term Incentive Plan (A&R 2020 LTIP), and approving Deloitte & Touche LLP as the company's auditor for fiscal year ended June 30, 2026.
  • The company ceased to be a 'controlled company' under Nasdaq Listing Rules as of November 19, 2024, after purchasing 3,562,341 common shares from The Resource Group International Limited (TRGI), reducing TRGI's beneficial ownership to approximately 13%. The company fully phased out of 'controlled company' exemptions by June 16, 2025.
  • The Board currently consists of eight directors, with five determined to be independent under Nasdaq listing standards.
  • The A&R 2020 LTIP proposes increasing the aggregate share reserve by an additional 650,000 common shares, bringing the total to 2,637,326.13 common shares, and extending the plan term to December 5, 2035.
  • The A&R 2020 LTIP also revises non-employee director annual compensation limits to $450,000 (or $900,000 in the first year of service) and explicitly prohibits repricing of underwater share options or share appreciation rights without shareholder approval.
  • For the fiscal year ended June 30, 2025, net income increased to $36.864 million from $33.655 million in FY2024, and adjusted net income rose to $43.001 million from $38.351 million.
  • EBITDA for FY2025 was $64.798 million, up from $60.961 million in FY2024, and adjusted EBITDA increased to $71.955 million from $65.176 million.
  • Free cash flow for FY2025 was $27.293 million, a slight increase from $27.045 million in FY2024.
  • Net cash significantly decreased from $61.193 million as of June 30, 2024, to $13.731 million as of June 30, 2025.
  • The three-year average burn rate for equity awards is 1.1%, and the total potential basic dilution/overhang from the LTIP is 16.4%.

Sentiment

Score: 7

Explanation: The company demonstrated solid financial growth across key profitability and cash flow metrics. The transition from a controlled company status and proposed governance enhancements are positive. However, the substantial decrease in net cash and potential dilution from the long-term incentive plan warrant careful consideration.

Positives

  • Net income increased to $36.864 million in FY2025 from $33.655 million in FY2024, demonstrating improved profitability.
  • Adjusted Net Income grew to $43.001 million in FY2025 from $38.351 million in FY2024, indicating stronger underlying business performance.
  • EBITDA increased to $64.798 million in FY2025 from $60.961 million in FY2024, and Adjusted EBITDA rose to $71.955 million from $65.176 million, reflecting healthy operational performance.
  • Free Cash Flow slightly increased to $27.293 million in FY2025 from $27.045 million in FY2024, showing continued cash generation.
  • The company successfully transitioned from a 'controlled company' status, enhancing corporate governance and increasing director independence with five out of eight directors now independent.
  • The proposed Amended and Restated 2020 Long-Term Incentive Plan (A&R 2020 LTIP) aims to attract and retain high-quality employees and directors by aligning their interests with long-term shareholder value creation.
  • The Board actively seeks director candidates from diverse backgrounds, with current board composition including 37.5% female directors and 37.5% racially/ethnically diverse directors.
  • The company has a policy prohibiting hedging and pledging transactions in its securities for employees and directors, promoting responsible share ownership.
  • The Audit Committee Chair's fees were increased by $15,000 annually to align with the company's peer group, recognizing the extensive work required for the role.
  • Annual equity grants for non-employee directors (50% restricted share units, 50% performance-based share units) were approved to align director compensation with peer group practices and shareholder interests.

Negatives

  • Net cash significantly decreased from $61.193 million as of June 30, 2024, to $13.731 million as of June 30, 2025, indicating a substantial reduction in liquidity.
  • The proposed A&R 2020 LTIP introduces a total potential basic dilution/overhang of 16.4%, which could impact existing shareholder value.
  • The additional 650,000 common shares requested under the A&R 2020 LTIP represent an aggregate market value of $23,946,000 as of October 14, 2025, which is a notable increase in potential equity compensation.
  • There were late Section 16(a) filings, including one Form 4 for Mr. Bruce Dawson and Form 3 filings for Mr. Andreas Wilkens and Mr. Mingzhe Zhuang, indicating minor compliance issues.

Risks

  • Actual results could differ materially from forward-looking statements due to changes in demand for services and macroeconomic conditions.
  • The shares available for issuance under the A&R 2020 LTIP are anticipated to last for about three years, but could last for a different period if actual grant rates or share price changes materially.
  • If the A&R 2020 LTIP is not approved, the company may be compelled to significantly increase the cash component of employee and director compensation, which may not align employee and director interests with shareholders and would increase cash expenses.
  • A technical malfunction or other situation could affect the ability of the Annual Meeting to satisfy requirements for a meeting of shareholders held by remote communication, potentially leading to adjournment.

Future Outlook

The company anticipates that the shares available for issuance following the approval of the Amended and Restated 2020 Long-Term Incentive Plan will last for approximately three years, based on historical grant rates and current share price, though this period could vary. The company believes its future success is contingent on its ability to attract, motivate, and retain high-quality employees and directors, for which equity-based awards are considered critical.

Management Comments

  • "We believe our future success depends in part on our ability to attract, motivate, and retain high quality employees and directors and that the ability to provide equity-based awards under the A&R 2020 LTIP is critical to achieving this success."
  • "We would be at a severe competitive disadvantage if we could not use share-based awards to recruit and compensate our employees and directors."

Industry Context

The company operates in the customer care and service industry, with directors possessing expertise in telecommunications, technology, and financial services sectors. The emphasis on robust executive and director compensation, particularly through equity, reflects a common strategy in competitive industries to attract and retain top talent. The transition from a 'controlled company' status aligns with broader corporate governance trends favoring increased independence and shareholder rights, which is generally viewed positively by the market.

Comparison to Industry Standards

  • Audit Committee Chair director fees were increased by $15,000 per year to bring these fees in alignment with the Company's peer group, based on a review by Exequity LLP.
  • Initial annual equity grants for non-employee directors were approved to bring the Company in alignment with its peer group, following recommendations from Exequity LLP.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorJohn LeoneNAOctober 24, 2024Resignation
DirectorGerald KleisterleeNADecember 5, 2024Retirement
DirectorNA (filled vacancy)Fiona BeckOctober 24, 2024Appointed by Board to fill Mr. Leone's vacancy
Appointed Director (TRGI)Fiona BeckPatrick McGinnisOctober 24, 2024Appointed by TRGI to replace Ms. Beck as its designated director
Appointed Director (TRGI)Gerald KleisterleeMingzhe (JJ) ZhuangDecember 5, 2024Appointed by TRGI to replace Mr. Kleisterlee
Director, Compensation Committee, Nominating and Governance CommitteeShuja KeenNADecember 31, 2024Resignation pursuant to Purchase Agreement terms
DirectorNA (filled vacancy)Karen BatungbacalJanuary 20, 2025Appointed by Board to fill Mr. Keen's vacancy
Designated Directors (TRGI)Daniella Ballou-Aares, Robert Dechant, John Jones, Patrick McGinnis, Mingzhe (JJ) ZhuangNADecember 31, 2024TRGI revoked appointments pursuant to Purchase Agreement
Director (reappointed)NA (filled vacancy)Daniella Ballou-Aares, Robert Dechant, John Jones, Patrick McGinnis, Mingzhe (JJ) ZhuangDecember 31, 2024Reappointed by Board to fill vacancies resulting from TRGI's revocation of appointments

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Controlled Company StatusThe company ceased to qualify as a 'controlled company' under Nasdaq Listing Rules as of November 19, 2024, after purchasing 3,562,341 common shares from TRGI. It fully phased out of related exemptions by June 16, 2025.November 19, 2024Enhances corporate governance by requiring a majority of independent directors and fully independent compensation and nominating/governance committees, aligning with broader market expectations for public companies.
Board IndependenceThe Board determined that five of its eight current directors (Mses. Ballou-Aares, Batungbacal, Beck and Messrs. McGinnis, Zhuang) are 'independent directors' under Nasdaq listing standards.Ongoing assessmentIncreases board oversight and reduces potential conflicts of interest, strengthening investor confidence in governance practices.
Board Leadership StructureThe Board maintains separate roles for Chairman (Mohammed Khaishgi) and CEO (Robert Dechant), with no formal policy on combining or separating these roles.OngoingAllows the Chairman to focus on board coordination and governance, while the CEO concentrates on company leadership and management, potentially improving strategic focus and oversight.
Director Nomination ProcessIndependent members of the Board are responsible for identifying, evaluating, and recommending director candidates, considering diversity and specific criteria.OngoingPromotes a merit-based and diverse board composition, ensuring candidates possess relevant experience and align with the company's needs and long-term growth.
Prohibition of Hedging and PledgingThe Insider Trading Policy prohibits employees (including officers) and directors from engaging in hedging and pledging transactions in company securities.OngoingAligns management and director interests with long-term shareholder value by preventing speculative or risk-reducing transactions that could undermine commitment to share price performance.
Audit Committee CharterThe Audit Committee is solely responsible for the approval of quarterly reports on Form 10-Q for filing with the SEC.OngoingStrengthens financial reporting oversight by centralizing responsibility for quarterly report approval within the independent Audit Committee.
Related Party Transaction PolicyThe Audit Committee is responsible for reviewing and approving related party transactions exceeding $120,000.OngoingEnsures that transactions with related parties are conducted at arm's length and are in the best interest of the company and its shareholders, mitigating potential conflicts of interest.

Related Party Transactions

  • Sublease of Office Space: Ibex Global Solutions, Inc. subleased office space in Washington, D.C. to TRG Holdings LLC (a wholly-owned indirect subsidiary of TRGI). The sublease ended October 31, 2024, but TRGI is currently a 'tenant at will' paying $12,203 per month plus 50% of operating expenses, real estate taxes, and additional charges.
  • Participation in Health and Welfare Plans: Employees of TRG Holdings LLC and its affiliates are permitted to participate in the health, dental, and life insurance plans offered by Ibex Global Solutions, Inc. TRG Holdings LLC is obligated to indemnify Ibex Global Solutions, Inc. for any claims arising from this participation.

Stakeholder Impact

  • Shareholders: Will vote on key governance matters, including director elections and the long-term incentive plan, directly influencing company direction and potential dilution. Benefit from improved financial performance and enhanced corporate governance.
  • Employees: The proposed A&R 2020 LTIP aims to attract, motivate, and retain high-quality employees through equity compensation, aligning their interests with company performance.
  • Directors: Compensation program includes cash retainers and new annual equity grants, with increased fees for the Audit Committee Chair. Board composition has seen several changes, including new appointments and reappointments.
  • TRGI: Its beneficial ownership has been reduced to approximately 13% after the company purchased 3,562,341 common shares, and it has lost its right to appoint directors. Continues to engage in related party transactions with the company.

Next Steps

  • Shareholders will vote on five proposals at the Annual General Meeting on December 5, 2025.
  • The Board will be authorized to fill any vacancies on the Board if approved by shareholders.
  • The Audit Committee will fix the remuneration of Deloitte & Touche LLP for the fiscal year ended June 30, 2026.
  • The company intends to file a Registration Statement on Form S-8 relating to the issuance of common shares under the A&R 2020 LTIP as soon as practicable after shareholder approval.
  • Shareholders wishing to submit proposals for the 2026 Annual Meeting must adhere to specific deadlines: June 30, 2026, for Rule 14a-8 proposals; September 11, 2026, for Non-Rule 14a-8 proposals; and October 6, 2026, for Universal Proxy Nominations.

Key Dates

DateDescription
April 1, 2013Third Party Services Agreement between Ibex Global Solutions, Inc. and TRG Holdings LLC.
April 2, 2015Employment agreement with Mr. Dechant.
September 2017Mr. Mohammed Khaishgi began serving as Chairman of the Board.
March 2018Ms. Daniella Ballou-Aares and Mr. John Jones became directors.
July 2019Mr. Robert Dechant began serving as CEO.
July 2020Ms. Fiona Beck became a director. Amended employment agreements with Mr. David Afdahl, Ms. Julie Casteel, and Mr. Bruce Dawson.
October 28, 2021Deloitte & Touche LLP began serving as the Company's auditor and independent registered public accounting firm.
December 15, 2021Sublease agreement for office space between Ibex Global Solutions, Inc. and TRG Holdings LLC.
November 1, 2022Lease amount payable by TRG Holdings LLC under sublease commenced.
August 14, 2023Employment agreement with Mr. Taylor Greenwald.
September 18, 2023Compensation Committee entered into a services agreement with Exequity LLP.
May 31, 2024Mr. Greenwald received a grant of Performance-Based Restricted Stock Units (PSUs).
July 1, 2024Start of the fiscal year for related party transactions.
September 18, 20247,500 shares of Mr. Greenwald's RSU award vested.
October 24, 2024Mr. John Leone resigned from the Board. Ms. Fiona Beck was appointed to fill Mr. Leone's vacancy. Mr. Robert Dechant's annual base salary increased from $600,000 to $650,000.
November 8, 2024Named executive officers were awarded restricted stock units (RSUs) and performance-based restricted stock units (PSUs).
November 19, 2024Company purchased 3,562,341 common shares from TRGI, resulting in the company no longer qualifying as a 'controlled company'.
December 5, 2024Mr. Gerald Kleisterlee retired from the Board. Mr. Mingzhe (JJ) Zhuang's directorship began. Ms. Beck, Messrs. Keen and Khaishgi were elected by shareholders.
December 31, 2024Mr. Shuja Keen resigned from the Board. Ms. Karen Batungbacal was appointed as a director, effective January 20, 2025. TRGI revoked the appointments of five designated directors, who were then reappointed by the Board.
January 20, 2025Ms. Karen Batungbacal's directorship became effective.
February 14, 2025New directors Karen Batungbacal, Patrick McGinnis, and Mingzhe Zhuang were each awarded 5,000 restricted share units.
April 1, 202525% of restricted share units awarded on February 14, 2025, vested.
May 2025Board approved an increase to the Audit Committee Chairperson's fees and initial annual equity grants for non-employee directors, effective following the Annual Meeting.
June 16, 2025Company fully phased out of 'controlled company' exemptions.
June 30, 2025Fiscal year end. Financial metrics and outstanding stock awards are reported as of this date.
July 1, 202525% of RSUs granted on November 8, 2024, vested.
September 30, 2025End of the First Performance Period for certain PSUs.
October 3, 2025Beneficial ownership of securities reported as of this date.
October 10, 2025Record date for qualification of shareholders to participate and vote in the Annual Meeting. Unvested performance stock options for Mr. Dechant and the executive officer group vest.
October 14, 2025Closing price of common shares on the Nasdaq Stock Market was $36.84 per share.
October 15, 2025The Administrator of the A&R 2020 LTIP is the Compensation Committee.
October 22, 2025Board approved and adopted the amendment and restatement of the Ibex Limited 2020 Long-Term Incentive Plan, subject to shareholder approval.
October 28, 2025Proxy statement and 2025 Annual Report were first mailed or made available.
December 5, 2025Date of the Annual General Meeting. The A&R 2020 LTIP is effective as of this date, subject to shareholder approval.
June 30, 2026Fiscal year for which the Audit Committee is authorized to fix the remuneration of Deloitte & Touche LLP. Deadline for Rule 14a-8 proposals for the 2026 Annual Meeting.
September 11, 2026Deadline for Non-Rule 14a-8 proposals for the 2026 Annual Meeting.
October 6, 2026Deadline for Universal Proxy Nominations for the 2026 Annual Meeting.
September 30, 2026End of the Second Performance Period for certain PSUs.
September 30, 2027End of the Third Performance Period for certain PSUs.
December 5, 2035The A&R 2020 LTIP plan term expires.

Recommendation

hold

The company demonstrates solid financial performance with year-over-year growth in net income, EBITDA, and free cash flow, which are positive indicators. The transition from a 'controlled company' status and the proposed enhancements to the long-term incentive plan are favorable for corporate governance and talent retention. However, the significant decrease in net cash from $61.193 million to $13.731 million in FY2025, coupled with the potential dilution from the expanded equity plan (16.4% total potential basic dilution/overhang), introduces a degree of caution. While the growth is encouraging, the cash position warrants monitoring, and the dilution could impact per-share value. Therefore, a 'hold' recommendation is appropriate to observe how these factors evolve.

Keywords

Proxy Statement, Annual General Meeting, Corporate Governance, Executive Compensation, Long-Term Incentive Plan, Director Election, Auditor Appointment, SEC Filing, Financial Performance, Nasdaq Listing, Controlled Company, Equity Awards, Shareholder Vote, IBEX Limited

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.